INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER

There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the comp...

Full description

Saved in:
Bibliographic Details
Main Authors Cherney Emily Charlotte, Kanyaboina Yadagiri, Roy Saumya, Nara Susheel Jethanand, Huang Audris, Sistla Ramesh Kumar, Markwalder Jay A, Thangathirupathy Srinivasan, Thangavel Soodamani, Pulicharla Nagalakshmi, Williams David K, Balog James Aaron, Seitz Steven P, Shan Weifang, Cheruku Srinivas
Format Patent
LanguageEnglish
Published 22.03.2018
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
Bibliography:Application Number: US201615564146